nVerses Capital’s Lam Research LRCX Stock Holding History

nVerses Capital’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,693	Closed	-$789K	–	444
2026 Q1	$789K	Buy	3,693 +1,737	+89%	+$388K	0.72%	1
2025 Q4	$335K	Buy	+1,956	New	+$304K	0.75%	23
2024 Q4	–	Sell	-12,000	Closed	-$979K	–	488
2024 Q3	$979K	Buy	12,000 +5,000	+71%	+$435K	0.45%	63
2024 Q2	$745K	Buy	7,000 +6,000	+600%	+$575K	0.45%	45
2024 Q1	$97.2K	Buy	+1,000	New	+$88K	0.23%	176

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

nVerses Capital's LRCX Position: Q2 2026 in Review

nVerses Capital sold out of Lam Research (LRCX) in Q2 2026, closing a stake of 3,693 shares — an estimated $789K sold.

nVerses Capital first reported a position in LRCX in Q1 2024 and held it in 5 quarters. The position peaked at $979K in Q3 2024. 2,656 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

nVerses Capital reported no remaining Lam Research position as of Q2 2026 after selling out during the quarter.
nVerses Capital sold 3,693 Lam Research shares in Q2 2026, an estimated $789K.
nVerses Capital first reported a position in Lam Research in Q1 2024 and held it in 5 quarters.
nVerses Capital's Lam Research position peaked at $979K in Q3 2024.
2,656 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on nVerses Capital's 13F filing for Q2 2026, filed 4 Aug 2026.